David Grimwade
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 123
- Acute Myeloid Leukemia Research 118
- Chronic Myeloid Leukemia Treatments 19
-
- Retinoids in leukemia and cellular processes 87
- Protein Degradation and Inhibitors 16
- Advanced biosensing and bioanalysis techniques 15
- Co-authors
- Alan K. BurnettKeith WheatleyRobert K. HillsChristine J. HarrisonHelen M. WalkerAnthony P. GoldstoneIan HannAnthony H. Goldstone
- Journals
- Blood (49 papers)British Journal of Haematology (24 papers)Leukemia (13 papers)Genes Chromosomes and Cancer (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
David Grimwade
150 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 12.7k
- Genetics 3.0k
- Public Health, Environmental and Occupational Health 4.5k
- Molecular Biology 8.4k
- Biochemistry 619
Countries citing papers authored by David Grimwade
This map shows the geographic impact of David Grimwade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grimwade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grimwade more than expected).
Fields of papers citing papers by David Grimwade
This network shows the impact of papers produced by David Grimwade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grimwade. The network helps show where David Grimwade may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Grimwade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2017 | 2 | |
| 3 | 2015 | 292 | |
| 4 | Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial Hit paper breakdown → | 2015 | 346 |
| 5 | COMBINED ANALYSES OF ROS, CELL CYCLE AND IMMUNOPHENOTYPE SHOWS THAT NORMAL HEMATOPOIETIC PROGENITOR SUBSETS HAVE A DIFFERENTIAL ROS PROFILE THAT IS LOST IN ACUTE MYELOID LEUKEMIA | 2013 | 1 |
| 6 | Refinement of cytogenetic classification in acute myeloid leukaemia: Determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials | 2010 | 29 |
| 7 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2350 |
| 8 | REFINEMENT OF CYTOGENETIC CLASSIFICATION IN AML: DETERMINATION OF PROGNOSTIC SIGNIFICANCE OF RARE RECURRING CHROMOSOMAL ABNORMALITIES AMONGST 5635 YOUNGER ADULTS TREATED IN THE UK MRC TRIALS | 2009 | 5 |
| 9 | 2006 | 3 | |
| 10 | The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia. | 2003 | 3 |
| 11 | Cytogenetics of childhood AML from UK medical research council treatment trials, AML10 & 12. | 2003 | 3 |
| 12 | Refinement of cytogenetic classification in AML: determination of prognostic significance of rare recurring chromosomal abnormalities amongst patients entered into the UK MRC AML 10 & 12 trials. | 2002 | 3 |
| 13 | Mutation analysis of the Fanconi Anaemia group A, C, E, F and G genes in sporadic acute myeloid leukaemia | 2001 | 0 |
| 14 | Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement. | 2001 | 3 |
| 15 | Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies" | 2000 | 30 |
| 16 | Detection of minimal residual disease (MRD) in APL by "real-time" RT-PCR: Analysis of cases entered into the UK MRC ATRA trial. | 1999 | 8 |
| 17 | The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial. | 1999 | 5 |
| 18 | Morphological presentation of acute promyelocytic leukemia (APL) lacking the classical t(15;17) with special reference to a series of 9 cases with t(11;17) | 1998 | 3 |
| 19 | The role of molecular diagnosis & residual disease monitoring in APL: Results of the MRC ATRA trial | 1998 | 2 |
| 20 | Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial. | 1996 | 6 |
About David Grimwade
David Grimwade is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Biochemistry and Genetics, having authored 152 papers that have together received 15.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (118 papers), Retinoids in leukemia and cellular processes (87 papers), Acute Lymphoblastic Leukemia research (47 papers), Chronic Myeloid Leukemia Treatments (19 papers), Protein Degradation and Inhibitors (16 papers), Advanced biosensing and bioanalysis techniques (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Drug-Induced Ocular Toxicity (8 papers). The work is most often cited by research in Hematology (12.7k citations), Genetics (3.0k citations), Public Health, Environmental and Occupational Health (4.5k citations), Molecular Biology (8.4k citations) and Biochemistry (619 citations). David Grimwade has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Alan K. Burnett, Keith Wheatley, Robert K. Hills, Christine J. Harrison, Helen M. Walker, Anthony P. Goldstone, Ian Hann, Anthony H. Goldstone, Sylvie Freeman and Fiona Oliver. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Genes Chromosomes and Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.